About Naishi

Naishi Project is a five-year HIV prevention, care and treatment program funded by the U.S. President’s Emergency Program for AIDS Relief (PEPFAR) through the U.S Centers for Disease Control and Prevention (CDC). NAISHI is a Swahili word meaning I LIVE and is focused on achieving HIV epidemic control in Machakos, Makueni and Kitui.

Working in collaboration with County Departments of Health, Naishi seeks to achieve HIV epidemic control by supporting the implementation and expansion of high quality, sustainable and comprehensive HIV prevention, care and treatment programs across CHS supported health facilities in the Eastern region. Some of the services offered include:

Through this project, CHS is contributing to the ambitious 90-90-90 targets to help end the HIV/AIDS epidemic

HIV Status Knowledge

By 2020, 90% of all people living with HIV will know their HIV status

Antiretroviral Therapy

By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy

Viral Suppression

By 2020, 90% of all people living with HIV will know their HIV status

Our Responses

  • Optimisation of HIV testing services to all eligible people in line with national guidelines
  • Comprehensive HIV care and treatment for people living with HIV
  • Prevention of mother-to-child transmission of HIV services
  • Integration of TB/HIV collaborative activities
  • Antiretroviral (ART) commodity management and support
  • Strengthening laboratory systems to support quality monitoring of all people living with HIV
  • Promoting and scaling up voluntary medical male circumcision among men, boys and male infants, as a critical HIV prevention intervention
  • Information systems management and monitoring and evaluation support

Annual Project Highlights

(As at September 2019)

80 CHS supported health facilities

812 CHS supported health care workers and volunteers across 217 facilities

First 90

552,499 HIV tests done80 CHS supported health facilities

8,293 people tested positive

Second 90

52,279 people currently on treatment

1,214 HIV Exposed Infants tested within 18 months of birth

2,056 infants initiated on ART Prophylaxis

Overall Retention Rate – 72%
Adults (20+) – 71%
Adolescents (15-19) – 76%
Children (0-14) – 79%

Third 90

Overall Viral Suppression Rate – 87%
Adults (20+) – 90%
Adolescents (15-19) – 73%
Children (0-14) – 76%

Latest News & Stories

Menu